PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)

PHASE2,PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped A combination of factors, including the dynamic nature of the COVID-19 pandemic and the successful vaccination program, has resulted in a very sharp decline in the number of patients with COVID-19

Conditions

Respiratory Viral Infection
Respiratory Tract Diseases
COVID-19 Respiratory Infection

Interventions

DRUG: RESP301 (a nitric oxide generating solution)
DRUG: Standard of Care (SOC)

Sponsor

Thirty Respiratory Limited